Generic Portal

— Research Explorer

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

Research output: Contribution to journal › Article › Academic › peer-review

Oncology

DOI

https://doi.org/10.1016/j.ymthe.2020.11.002
Final published version

Fenne L Komdeur
Amrita Singh
Stephanie van de Wall
Janneke J M Meulenberg
Annemarie Boerma
Baukje Nynke Hoogeboom
Sterre T Paijens
Marco de Bruyn
Ed Schuuring
Joke Regts
Ruben Marra
Naomi Werner
Jessica Sluis
Ate G J van der Zee
Jan C Wilschut
Derk P Allersma
Coba J van Zanten
Jos G W Kosterink
Annelies Jorritsma-Smit
Refika Yigit
Hans W Nijman
Toos Daemen

Original language	English
Pages (from-to)	611-625
Number of pages	15
Journal	Molecular therapy
Volume	29
Issue number	2
DOIs	https://doi.org/10.1016/j.ymthe.2020.11.002
Publication status	Published - 3 Feb 2021

Research areas

Vvax001, alphavirus replicon vaccine, cervical intraepithelial neoplasia, human papillomavirus, immunotherapy, recombinant Semliki Forest virus vector, therapeutic vaccine

ID: 15639645